Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Orvosi Hetilap|October 28, 2008
[The level of carbohydrate-deficient transferrin is highly increased in bodybuilders]György Szabó, Eva Keller, Gergely Szabó, et al.
Orvosi Hetilap|April 21, 2006
[The role of antioxidants in prevention]Eszter Németh, Janos Feher, Viktor Nagy, et al.
Orvosi Hetilap|February 16, 2016
[Various pathways leading to the progression of chronic liver diseases]Anna Egresi, Gabriella Lengyel, Anikó Somogyi, et al.
Orvosi Hetilap|May 28, 2019
[Hepatitis C virus infection and hepatocarcinogenesis]Evelin Berta, Anna Egresi, Anna Bacsárdi, et al.
Orvosi Hetilap|September 20, 2006
[Granulomatous hepatitis successfully treated with ursodeoxycholic acid]Eszter Németh, Elemér Bugovics, Gabriella Lengyel, et al.
Orvosi Hetilap|May 16, 2006
[Association of chronic hepatitis C and lichen planus--in two patients]Beáta Podányi, Gabriella Lengyel, András Kiss, et al.
Orvosi Hetilap|May 27, 2020
Changes in endogenous metal element concentrations in various aetiologies of chronic liver diseaseZsófia Gáspár, Anna Egresi, Gabriella Lengyel, et al.
Orvosi Hetilap|November 24, 2004
[Combined antiviral treatment in a patient with recurrent chronic hepatitis C after liver transplantation]Tímea Csák, Anikó Folhoffer, Andrea Horváth, et al.
Orvosi Hetilap|September 4, 2018
[The role of gut microbiota in chronic liver diseases, and treatment possibilities]Krisztina Hagymási, Anna Bacsárdi, Anna Egresi, et al.
Infectious Diseases and Therapy|May 28, 2016
Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo TrialPeter Ferenci, Florin A Caruntu, Gabriella Lengyel, et al.
Pageof 9